Indapta Therapeutics Inc. announced it raised $33.6 Million in an initial filing from an offering of $67.1 Million
Indapta Therapeutics Inc. announced it raised $33.6 Million in an initial filing from an offering of $67.1 Million
02/10/22, 6:53 PM
Location
Money raised
$33.6 million
Industry
biotechnology
Company Info
Location
5000 montrose blvd.
houston, texas, united states
Additional Info
Indapta is a privately-held company focused on developing and bringing to market a diverse pipeline of cell therapies to treat the still unmet medical needs of patients with blood and solid-tumor cancers as well as autoimmune diseases. The company’s proprietary robust platform of naturally-occurring g-NK cells is specifically designed to create best-in-class, highly potent, more accessible, and scalable cell therapies.